{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:01:49Z","timestamp":1769205709044,"version":"3.49.0"},"reference-count":15,"publisher":"European Respiratory Society (ERS)","issue":"6","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,6,11]]},"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1183\/13993003.00921-2018","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T10:55:21Z","timestamp":1529578521000},"page":"1800921","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent"],"prefix":"10.1183","volume":"51","author":[{"given":"Michael","family":"Kreuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"2024101909473015000_51.6.1800921.1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151425"},{"key":"2024101909473015000_51.6.1800921.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02316-2014"},{"key":"2024101909473015000_51.6.1800921.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"2024101909473015000_51.6.1800921.4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-018-0769-0","article-title":"Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases \u2013 a claims data analysis","volume":"19","author":"Schwarzkopf","year":"2018","journal-title":"Respir Res"},{"key":"2024101909473015000_51.6.1800921.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.69.4.512"},{"key":"2024101909473015000_51.6.1800921.6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S2213-2600(17)30219-9","article-title":"Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?","volume":"5","author":"Johannson","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101909473015000_51.6.1800921.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.3.794"},{"key":"2024101909473015000_51.6.1800921.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00488-2016"},{"key":"2024101909473015000_51.6.1800921.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0138OC"},{"key":"2024101909473015000_51.6.1800921.10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","article-title":"Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2024101909473015000_51.6.1800921.11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","article-title":"Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis","volume":"4","author":"Kreuter","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024101909473015000_51.6.1800921.12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000468546","article-title":"Antiacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received pirfenidone","volume":"93","author":"Kreuter","year":"2017","journal-title":"Respiration"},{"key":"2024101909473015000_51.6.1800921.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00376-2018"},{"key":"2024101909473015000_51.6.1800921.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00104105"},{"key":"2024101909473015000_51.6.1800921.15","doi-asserted-by":"crossref","unstructured":"Raghu G . Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years. Eur Respir J 2017; 50: 1701209.","DOI":"10.1183\/13993003.01209-2017"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00921-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:58:29Z","timestamp":1740380309000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00921-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,21]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1183\/13993003.00921-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00921-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}